Initial experience with golimumab in clinical practice for ulcerative colitis

Initial experience with golimumab in clinical practice for ulcerative colitis

Background: Golimumab is a TNF-blocking agent indicated as a second-line therapy in ulcerative colitis. Purpose: To research the effectiveness and safety of golimumab in patients with ulcerative colitis in clinical practice. Methods: Retrospective study of the effectiveness and safety of golimumab i...

Full description

Bibliographic Details
Main Authors:	Luisa Castro-Laria, Federico Argüelles-Arias, Valle García-Sánchez, José Manuel Benítez, Ramón Fernández-Pérez, Ana María Trapero-Fernández, Francisco Gallardo-Sánchez, Héctor Pallarés-Manrique, María Gómez-García, María José Cabello-Tapia, Aurora Talavera-Fabuel, Ana Bejarano-García, Eduardo Leo-Carnerero, Álvaro Hernández-Martínez, Ángel Caunedo-Álvarez, Juan Manuel Herrerías-Gutiérrez
Format:	Article
Language:	English
Published:	Aran Ediciones
Series:	Revista Espanola de Enfermedades Digestivas
Subjects:	golimumab ulcerative colitis tnf-blocking agent naive patient non-naive patient
Online Access:	http://scielo.isciii.es/scielo.php?script=sci_arttext&pid=S1130-01082016000300004&lng=en&tlng=en

Similar Items

Preference for a prefilled syringe or an auto-injection device for delivering golimumab in patients with moderate-to-severe ulcerative colitis: a randomized crossover study
by: Vermeire S, et al.
Published: (2018-07-01)

Increased risk factors associated with lower BMD in antiretroviral-therapy–naïve HIV-infected adult male
by: Patricia Atencio, et al.
Published: (2021-06-01)

Golimumab for Rheumatoid Arthritis
by: Eleftherios Pelechas, et al.
Published: (2019-03-01)

Golimumab in radiographic and nonradiographic axial spondyloarthritis: a review of clinical trials
by: Toussirot E, et al.
Published: (2016-07-01)

Golimumab Therapy in Ulcerative Colitis
by: Won Moon
Published: (2016-02-01)

Long-term effectiveness and safety of infliximab, golimumab and golimumab-IV in rheumatoid arthritis patients from a Canadian prospective observational registry
by: Proton Rahman, et al.
Published: (2020-09-01)

Adherence to treatment with adalimumab, golimumab and ustekinumab in patients with inflammatory bowel disease
by: María Calvo-Arbeloa, et al.
Published: (2020-03-01)

GOLIMUMAB — A NEW TNF α-BLOCKER. THE REVIEW OF THE EFFICACY AND SAFETY EVALUATION RESULTS
by: R. V. Denisova, et al.
Published: (2012-07-01)

Benefit–risk assessment of golimumab in the treatment of refractory ulcerative colitis
by: Pugliese D, et al.
Published: (2016-02-01)

Golimumab in the treatment of psoriatic arthritis: efficacy and safety
by: Tatiana Viktorovna Korotaeva, et al.
Published: (2015-09-01)

Real-life effectiveness of Golimumab in biologic-naïve patients with rheumatoid arthritis - data from the Rheumatic Diseases Portuguese Register (Reuma.pt)
by: Ana Filipa Mourão, et al.
Published: (2017-04-01)

PROTEASE INHIBITOR NARLAPREVIR IN THERAPY OF HEPATITIS C VIRUS GENOTYPE 1 INFECTION IN TREATMENT-NAÏVE PATIENTS WITHOUT CIRRHOSIS: PHARMACOECONOMIC EVALUATION
by: A. V. Rudakova, et al.
Published: (2017-04-01)

Dose Adjustment of Methotrexate Administered Concomitantly with Golimumab for Rheumatoid Arthritis in Japanese Real-World Clinical Settings
by: Fumiko Yamairi, et al.
Published: (2020-08-01)

Golimumab in juvenile idiopathic arthritis-associated uveitis unresponsive to Adalimumab
by: Sofia Lanz, et al.
Published: (2021-08-01)

Efficacy of golimumab in treating uveitis in patients with ankylosing spondylitis
by: T. V. Dubinina, et al.
Published: (2016-09-01)

Prevalence of resistance to integrase strand-transfer inhibitors (INSTIs) among untreated HIV-1 infected patients in Morocco
by: Najwa Alaoui, et al.
Published: (2018-06-01)

The tumor necrosis factor-α inhibitor golimumab in the treatment of rheumatoid arthritis
by: Natalia Vladimirovna Chichasova
Published: (2014-12-01)

Grounding Naïve Physics and Optics in Perception
by: Ivana Bianchi, et al.
Published: (2014-12-01)

Will savings from biosimilars offset increased costs related to dose escalation? A comparison of infliximab and golimumab for rheumatoid arthritis
by: Jeffrey R. Curtis, et al.
Published: (2019-12-01)

Genetic diversity and primary resistance among HIV-1-positive patients from Maringá, Paraná, Brazil
by: Karine Vieira Gaspareto, et al.
Published: (2012-08-01)

Why golimumab in the treatment of psoriatic arthritis, ankylosing spondylitis and rheumatoid arthritis?
by: M. Rossini, et al.
Published: (2015-03-01)

Paradoxical Reaction to Golimumab: Tumor Necrosis Factor α Inhibitor Inducing Psoriasis Pustulosa
by: Marien Siqueira Soto Lopes, et al.
Published: (2013-11-01)

Efficacy of golimumab in the treatment of patients with ankylosing spondylitis (according to the data of a long-term follow-up)
by: A. V. Smirnov, et al.
Published: (2015-03-01)

Association Between Nursing Support Levels and Effectiveness of Golimumab in the Management of Patients with Rheumatologic Diseases
by: Hermine Leroi, et al.
Published: (2020-05-01)

Exploring the relation between People’s Theories of Intelligence and Beliefs about Brain Development
by: Ashley J Thomas, et al.
Published: (2015-07-01)

Naive Psychology: Preschoolers' Understanding of Intention and False Belief and Its Relationship to Mental Word
by: Jian, Jianhua
Published: (2006)

Сost-effectiveness of the second wave of protease inhibitors in the treatment of chronic hepatitis C (genotype 1) in patients not previously treated with antiviral drugs, and for relapsed disease
by: A. V. Rudakova, et al.
Published: (2016-04-01)

Cost-effectiveness of narlaprevir in the chronic hepatitis C (genotype 1) therapy in treatment-naïve patients and relapsers
by: D. A. Gusev, et al.
Published: (2016-11-01)

Phenotypic and Genotypic Shifts in Hepatitis B Virus in Treatment-Naive Patients, Taiwan, 2008–2012
by: Chau-Ting Yeh, et al.
Published: (2017-05-01)

Sex differences in association between cognitive impairment and clinical correlates in Chinese patients with first-episode drug-naïve schizophrenia
by: Na Zhao, et al.
Published: (2021-04-01)

Insulin perception among insulin-naïve type-2 diabetes mellitus patients in Pakistan
by: Ahsan Saleem, et al.
Published: (2016-12-01)

Metabolic syndrome and its components among HIV/AIDS patients on Antiretroviral Therapy and ART-Naïve Patients at the University of Calabar Teaching Hospital, Calabar, Nigeria
by: Djeufouata, J., et al.
Published: (2022)

Long-term effectiveness and safety of infliximab and golimumab in ankylosing spondylitis patients from a Canadian prospective observational registry
by: Proton Rahman, et al.
Published: (2020-11-01)

Intravitreal dexamethasone implant in naïve and previously treated patients with diabetic macular edema: a retrospective study
by: Marta Medina-Baena, et al.
Published: (2020-10-01)

A case of idiopathic necrotizing scleritis with secondary glaucoma treated successfully with golimumab and Ahmed valve implantation
by: Parthopratim Dutta Majumder, et al.
Published: (2019-01-01)

Time course of changes in the clinical and instrumental manifestations of coxitis in patients with ankylosing spondylitis during golimumab therapy: a GO-COX study. Preliminary results
by: Sh. Erdes, et al.
Published: (2019-07-01)

Efficacy and safety of intravenous golimumab plus methotrexate in patients with rheumatoid arthritis aged < 65 years and those ≥ 65 years of age
by: John Tesser, et al.
Published: (2019-08-01)

Long-term results of golimumab therapy for rheumatoid arthritis. Therapy compliance issues
by: N. V. Chichasova
Published: (2016-06-01)

Comparative analysis of US real-world dosing patterns and direct infusion-related costs for matched cohorts of rheumatoid arthritis patients treated with infliximab or intravenous golimumab
by: Ellis LA, et al.
Published: (2019-01-01)

Golimumab in the treatment of extra-skeletal manifestations of ankylosing spondylitis
by: A. B. Demina
Published: (2019-10-01)

Cannot write session to /tmp/vufind_sessions/sess_mt491qftai6r9be5u6fdslgifp